271 related articles for article (PubMed ID: 29197335)
1. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
[TBL] [Abstract][Full Text] [Related]
2. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
[TBL] [Abstract][Full Text] [Related]
3. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
[TBL] [Abstract][Full Text] [Related]
5. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
6. Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
Yu H; MacIsaac D; Wong JJ; Sellers ZM; Wren AA; Bensen R; Kin C; Park KT
Aliment Pharmacol Ther; 2018 Feb; 47(3):364-370. PubMed ID: 29164650
[TBL] [Abstract][Full Text] [Related]
7. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
[TBL] [Abstract][Full Text] [Related]
8. Mental Health Costs of Inflammatory Bowel Diseases.
Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
[TBL] [Abstract][Full Text] [Related]
9. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
[TBL] [Abstract][Full Text] [Related]
10. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
[TBL] [Abstract][Full Text] [Related]
11. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.
Limsrivilai J; Stidham RW; Govani SM; Waljee AK; Huang W; Higgins PD
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):385-392.e2. PubMed ID: 27645518
[TBL] [Abstract][Full Text] [Related]
12. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
Targownik LE; Kaplan GG; Witt J; Bernstein CN; Singh H; Tennakoon A; Aviña Zubieta A; Coward SB; Jones J; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN; Benchimol EI
Am J Gastroenterol; 2020 Jan; 115(1):128-137. PubMed ID: 31895723
[TBL] [Abstract][Full Text] [Related]
14. Health care resource utilization in inflammatory bowel disease.
Longobardi T; Bernstein CN
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):731-43. PubMed ID: 16631415
[TBL] [Abstract][Full Text] [Related]
15. Variations in care: a retrospective database analysis of healthcare utilization patterns for patients with inflammatory bowel disease.
David G; Gunnarsson C; Lofland JH
J Med Econ; 2015 Feb; 18(2):137-44. PubMed ID: 25335098
[TBL] [Abstract][Full Text] [Related]
16. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology and socio-economic aspects of chronic inflammatory bowel diseases in Switzerland].
Schoepfer A; Safroneeva E
Ther Umsch; 2019 Jan; 75(5):255-259. PubMed ID: 30700239
[TBL] [Abstract][Full Text] [Related]
18. Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
van der Have M; Mangen MJ; van der Valk ME; Smeets HM; van Bodegraven A; Dijkstra G; Fidder HH; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
Inflamm Bowel Dis; 2014 Apr; 20(4):637-45. PubMed ID: 24518606
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients.
Nguyen GC; Patel H; Chong RY
Am J Gastroenterol; 2010 Feb; 105(2):371-7. PubMed ID: 19809406
[TBL] [Abstract][Full Text] [Related]
20. [Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main Region: results of the first integrated health-care project IBD in Germany].
Blumenstein I; Tacke W; Filmann N; Zosel C; Bock H; Heuzeroth V; Zeuzem S; Schröder O
Z Gastroenterol; 2013 Jul; 51(7):613-8. PubMed ID: 23696113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
